[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @ivobuild Ivo Ivo posts on X about $iova, $repl, holders the most. They currently have XX followers and X posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::1594325535555043328/interactions)  - X Week XXXXX +276% - X Month XXXXX -XX% - X Months XXXXXX +61% - X Year XXXXXX +1,087% ### Mentions: X [#](/creator/twitter::1594325535555043328/posts_active)  - X Week X no change - X Month XX +22% - X Months XX -XXXX% - X Year XX +510% ### Followers: XX [#](/creator/twitter::1594325535555043328/followers)  - X Week XX +1.50% - X Month XX no change - X Months XX +63% ### CreatorRank: undefined [#](/creator/twitter::1594325535555043328/influencer_rank)  ### Social Influence [#](/creator/twitter::1594325535555043328/influence) --- **Social topic influence** [$iova](/topic/$iova) #6, [$repl](/topic/$repl) 50%, [holders](/topic/holders) XX% **Top accounts mentioned or mentioned by** [@yss4318](/creator/undefined) **Top assets mentioned** [Iovance Biotherapeutics, Inc. Common Stock (IOVA)](/topic/$iova) ### Top Social Posts [#](/creator/twitter::1594325535555043328/posts) --- Top posts by engagements in the last XX hours "Good news today for $IOVA holders. Their last competitor is gone. $REPL: At this time a path forward under the accelerated approval pathway has not been determined" [X Link](https://x.com/ivobuild/status/1968678900180963785) [@ivobuild](/creator/x/ivobuild) 2025-09-18T14:10Z XX followers, 1644 engagements "$IOVA It has treated a metastatic lung cancer patient with TIL therapy for the first time as part of a clinical trial at its research arm 🔥🔥🔥 The tumour sample is then sent to manufacturing facilities in the US" [X Link](https://x.com/ivobuild/status/1969053639428686037) [@ivobuild](/creator/x/ivobuild) 2025-09-19T14:59Z XX followers, 5365 engagements "$REPL $IOVA The biggest problem with cancer treatments is DURABILITY. They dont last REPLs ORR isnt bad but the real challenge is also achieving durability where IOVA excels with 4-5 years. It is a marathon not a sprint" [X Link](https://x.com/ivobuild/status/1980265268669505861) [@ivobuild](/creator/x/ivobuild) 2025-10-20T13:30Z XX followers, 1081 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@ivobuild Ivo
Ivo posts on X about $iova, $repl, holders the most. They currently have XX followers and X posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Week XXXXX +276%
- X Month XXXXX -XX%
- X Months XXXXXX +61%
- X Year XXXXXX +1,087%
Mentions: X #
- X Week X no change
- X Month XX +22%
- X Months XX -XXXX%
- X Year XX +510%
Followers: XX #
- X Week XX +1.50%
- X Month XX no change
- X Months XX +63%
CreatorRank: undefined #
Social Influence #
Social topic influence $iova #6, $repl 50%, holders XX%
Top accounts mentioned or mentioned by @yss4318
Top assets mentioned Iovance Biotherapeutics, Inc. Common Stock (IOVA)
Top Social Posts #
Top posts by engagements in the last XX hours
"Good news today for $IOVA holders. Their last competitor is gone. $REPL: At this time a path forward under the accelerated approval pathway has not been determined"
X Link @ivobuild 2025-09-18T14:10Z XX followers, 1644 engagements
"$IOVA It has treated a metastatic lung cancer patient with TIL therapy for the first time as part of a clinical trial at its research arm 🔥🔥🔥 The tumour sample is then sent to manufacturing facilities in the US"
X Link @ivobuild 2025-09-19T14:59Z XX followers, 5365 engagements
"$REPL $IOVA The biggest problem with cancer treatments is DURABILITY. They dont last REPLs ORR isnt bad but the real challenge is also achieving durability where IOVA excels with 4-5 years. It is a marathon not a sprint"
X Link @ivobuild 2025-10-20T13:30Z XX followers, 1081 engagements